Literature DB >> 9682036

Transcriptional activation through the vitamin D receptor in osteoblasts.

D M Kraichely1, P N MacDonald.   

Abstract

Osteoblasts are bone-forming cells that play an essential role in the development and maintenance of a mineralized bone extracellular matrix and they are target cells for vitamin D. Osteoblasts express vitamin D receptors (VDR) and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] regulates the expression of osteoblastic-specific genes such as osteocalcin and osteopontin. VDR is a ligand-inducible transcription factor which heterodimerizes with retinoid X receptor (RXR) and binds as a heterodimer to vitamin D-responsive elements (VDREs) in the promoter region of vitamin-D responsive genes, ultimately leading to their increased transcription. Important structural aspects of the VDR and the role that each functional domain plays in mediating VDR action in the context of the osteoblast are discussed. A summary of the potential molecular mechanisms involved in VDR-activated transcription highlighting the importance of interactions between the VDR and general transcription factors (GTFs), TBP-associated factors (TAFIIs), and nuclear receptor coactivator and corepressor proteins are reviewed. These interactions have a role in linking the VDR-RXR heterodimer to the transcriptional pre-initiation complex (PIC) and in regulating the transcription of vitamin D-dependent genes. In addition, recent findings suggest that these interactions are important for regulating the accessibility to promoters by modifying the acetylation state of histones. The complex interplay that occurs between VDR and these various factors to determine the overall transcriptional activity of vitamin D-responsive genes will be summarized.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682036     DOI: 10.2741/a325

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  8 in total

1.  1alpha,25(OH)2-vitamin D3 membrane-initiated calcium signaling modulates exocytosis and cell survival.

Authors:  Zhang Xiaoyu; Biswas Payal; Owraghi Melissa; Laura P Zanello
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-08       Impact factor: 4.292

2.  Osteogenic differentiation of stem cells alters vitamin D receptor expression.

Authors:  Rene Olivares-Navarrete; Ken Sutha; Sharon L Hyzy; Daphne L Hutton; Zvi Schwartz; Todd McDevitt; Barbara D Boyan
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

3.  Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts.

Authors:  Jiaxuan Chen; Rene Olivares-Navarrete; Yun Wang; Tyler R Herman; Barbara D Boyan; Zvi Schwartz
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

4.  1alpha,25(OH)(2) vitamin D(3) induction of ATP secretion in osteoblasts.

Authors:  Payal Biswas; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

5.  Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis.

Authors:  Sylvain Marcellini; Carola Bruna; Juan P Henríquez; Miguel Albistur; Ariel E Reyes; Elias H Barriga; Berta Henríquez; Martín Montecino
Journal:  BMC Evol Biol       Date:  2010-03-17       Impact factor: 3.260

6.  Vitamin D receptor-dependent 1 alpha,25(OH)2 vitamin D3-induced anti-apoptotic PI3K/AKT signaling in osteoblasts.

Authors:  Xiaoyu Zhang; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

7.  Association analysis of vitamin D receptor gene polymorphisms in North England population with Type 2 diabetes mellitus.

Authors:  Naila Abdul Sattar; Sumera Shaheen; Fatma Hussain; Amer Jamil
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

Review 8.  Vitamin D and the Promotion of Long-Term Metabolic Health from a Programming Perspective.

Authors:  Saranya Palaniswamy; Dylan Williams; Marjo-Riitta Järvelin; Sylvain Sebert
Journal:  Nutr Metab Insights       Date:  2016-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.